Cernak; Timothy A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cernak; Timothy A..The latest application filed is for "novel substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (ido) inhibitors".
- Cernak; Timothy A. - Boston MA
| Patent | Date |
|---|---|
| Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,988,487 - Liu , et al. April 27, 2 | 2021-04-27 |
| Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200231606 - Liu; Kun ; et al. | 2020-07-23 |
| Pyrimidone carboxamide compounds as PDE2 inhibitors Grant 9,815,796 - Shen , et al. November 14, 2 | 2017-11-14 |
| Soluble guanylate cyclase activators Grant 9,783,552 - Han , et al. October 10, 2 | 2017-10-10 |
| Pyrimidone Carboxamide Compounds As Pde2 Inhibitors App 20170015633 - Shen; Dong Ming ; et al. | 2017-01-19 |
| Mineralocorticoid receptor antagonists Grant 9,511,052 - Cernak , et al. December 6, 2 | 2016-12-06 |
| Soluble Guanylate Cyclase Activators App 20160304537 - Han; Xiaoqing ; et al. | 2016-10-20 |
| Mineralocorticoid Receptor Antagonists App 20150182503 - Cernak; Timothy A. ; et al. | 2015-07-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 